IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 278 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $187,510 | -35.4% | 41,211 | 0.0% | 0.00% | -33.3% |
| Q2 2023 | $290,125 | +15.2% | 41,211 | 0.0% | 0.00% | -25.0% |
| Q1 2023 | $251,799 | -23.1% | 41,211 | -19.5% | 0.00% | -33.3% |
| Q4 2022 | $327,238 | -33.4% | 51,211 | 0.0% | 0.01% | -33.3% |
| Q3 2022 | $491,000 | -13.1% | 51,211 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $565,000 | -33.8% | 51,211 | 0.0% | 0.01% | -10.0% |
| Q1 2022 | $853,000 | -27.0% | 51,211 | -16.3% | 0.01% | -16.7% |
| Q4 2021 | $1,169,000 | -22.5% | 61,211 | 0.0% | 0.01% | -29.4% |
| Q3 2021 | $1,509,000 | +164.3% | 61,211 | +178.9% | 0.02% | +88.9% |
| Q2 2021 | $571,000 | -65.0% | 21,946 | -55.7% | 0.01% | -73.5% |
| Q3 2020 | $1,630,000 | +1.9% | 49,504 | -15.0% | 0.03% | -15.0% |
| Q2 2020 | $1,599,000 | – | 58,240 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
| Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
| Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
| Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
| Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
| Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
| QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
| Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |